Skip to Content Skip to Main menu

SEOHAE HOLDINGS CORP .

About us

CEO Message

WELCOME!
주식회사 서해홀딩스
홈페이지에 오신 여러분을
환영합니다.

Hello.


Status of Global Technology Licensing

Recently Biotechnology and New Drug technology is developing rapidly, and several biotech venture companies are actively pursuing global technology transfer and licensing. However, most Universities, government-funded Research Institutes and early-stage Biotech Ventures are not fully recognized for their value of their excellent Biotechnologies due to the difficulties of finding suitable partner companies. They also face challenges in smoothly facilitating global technology transfer due to various issues such as lack of funding, experience, time, and business development expertise. As a result, they are in urgent need of assistance with global technology licensing.


Starting a Business Development for Global Licensing

To address this need, we founded Seohae Holdings Corporation to assist Universities, government-funded Research Institutes and early-stage Biotech Ventures with Global Licensing, Business Developing and Partnering.


Possessing Excellent Capabilities for Global Technology Licensing

We have extensive experience in technology commercialization from Universities, government-funded Research Institutes, and Biotech Ventures. Our team consists of outstanding human resources and we have a robust track record in domestic and Global Technology Licensing. We have established a wide network with global pharmaceutical companies, allowing us to accurately understand their technology demands and the licensing needs for technologies they seek. Hence, we can help our clients successfully license their technologies on a global scale.


Establishing the Optimal Global Licensing Strategy

To facilitate global technology transfer, a deep understanding of the global market is essential, as well as a good grasp of the technology transfer patterns of big pharmaceutical companies, which informs the appropriate approach strategy. Furthermore, since the requirements set by global big pharmaceutical companies vary for each technology and indication, it is crucial to prepare optimal conditions in advance and develop a suitable global technology transfer strategy tailored to each stage of the new drug pipeline. This will enable us to identify companies in need and promote global technology transfer effectively. In this respect, we can provide optimal consulting services that meet the needs of our clients and assist them in formulating strategies.


Successful Global Licensing

If you require assistance with Global Licensing, Global Business Development, P:artnering and Global Technology Transfer, please feel free to contact us at any time. We are committed to providing our best support. We look forward to your continued cooperation.


Thank you.

All employees of Seohae Holdings Corporation.